Obagi Medical Retinol + PHA Refining Night Cream

Obagi Medical has unveiled its newest innovation in professional-grade skincare, the Retinol + PHA Refining Night Cream, offering a powerful yet gentle formula designed to transform the skin while you sleep. The new addition expands the brand’s respected retinol portfolio with a dual-action cream that targets skin texture, tone and blemishes in just four weeks.

At the heart of the formulation is 0.3 percent entrapped retinol, a slow-release form of vitamin A encapsulated in microspheres to deliver maximum effect with minimal irritation. Paired with polyhydroxy acid (PHA), which provides gentle exfoliation, the formula works to resurface the skin and refine texture without the harsh side effects often associated with traditional retinoids.

To balance the exfoliating action, the cream includes eight deeply hydrating ingredients, among them sodium hyaluronate, vitamin E, squalane and glycerin, ensuring skin remains nourished throughout the night.

According to clinical trials, 90 percent of users reported visible improvements in skin smoothness within four weeks, while a further 90 percent noticed a reduction in the appearance of blemishes. The cream also improved skin tone evenness by 10 percent, making it a suitable choice for those with sensitivity or concerns about tolerance.

“Obagi is renowned for retinols that cause minimal irritation with maximum proven clinical results,” said Simone Shoffman, Head of Education and Clinical at Healthxchange. “This balanced formulation offers an effective and accessible entry point for retinol newcomers, as well as those with skin sensitivity.”

The Retinol + PHA Refining Night Cream is available now, priced at £100 from skinstation.co.uk and authorised Obagi Medical providers.